Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Mots-C

Mitochondrial open reading frame of the 12S rRNA-c, MT-RNR1, Mitochondrial-derived peptide MOTS-c

Quick Stats
Studies 137
Trials 5
Score 4
2021 pubmed

A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c.

Zempo. Hirofumi H; Kim. Su-Jeong SJ; Fuku. Noriyuki N; Nishida. Yuichiro Y; Higaki. Yasuki Y; Wan. Junxiang J; Yen. Kelvin K; Miller. Brendan B; Vicinanza. Roberto R; Miyamoto-Mikami. Eri E; Kumagai. Hiroshi H; Naito. Hisashi H; Xiao. Jialin J; Mehta. Hemal H HH; Lee. Changhan C; Hara. Megumi M; Patel. Yesha M YM; Setiawan. Veronica W VW; Moore. Timothy M TM; Hevener. Andrea L AL; Sutoh. Yoichi Y; Shimizu. Atsushi A; Kojima. Kaname K; Kinoshita. Kengo K; Arai. Yasumichi Y; Hirose. Nobuyoshi N; Maeda. Seiji S; Tanaka. Keitaro K; Cohen. Pinchas P

Key Findings

  • The m.1382A>C mtDNA variant changes MOTS‑c from K14 to Q14, reducing its insulin‑sensitizing effect.
  • Male carriers of the C‑allele have a higher prevalence of type‑2 diabetes, particularly when they have low physical activity.
  • In mice, normal MOTS‑c improves glucose tolerance and reduces weight, but the K14Q‑MOTS‑c version does not, mirroring the human data.

Practical Outcomes

  • If you’re interested in MOTS‑c supplementation, consider getting your mtDNA tested for the m.1382A>C variant; carriers may see less benefit. Prioritizing regular exercise is especially important for male carriers to lower diabetes risk. For those with the K14Q version, exploring alternative insulin‑sensitizing strategies or peptides may be more effective.

Summary

A common Asian mitochondrial DNA change (m.1382A>C) creates a slightly different version of the peptide MOTS‑c (K14Q). This version works less well at improving insulin sensitivity, so men who carry it are more likely to develop type‑2 diabetes, especially if they are not physically active. Regular exercise can offset some of this risk, and the normal MOTS‑c peptide still helps in animal studies, but the altered K14Q version does not.

Abstract

Type 2 Diabetes (T2D) is an emerging public health problem in Asia. Although ethnic specific mtDNA polymorphisms have been shown to contribute to T2D risk, the functional effects of the mtDNA polymorphisms and the therapeutic potential of mitochondrial-derived peptides at the mtDNA polymorphisms are underexplored. Here, we showed an Asian-specific mitochondrial DNA variation m.1382A&gt;C (rs111033358) leads to a K14Q amino acid replacement in MOTS-c, an insulin sensitizing mitochondrial-derived peptide. Meta-analysis of three cohorts (n = 27,527, J-MICC, MEC, and TMM) show that males but not females with the C-allele exhibit a higher prevalence of T2D. In J-MICC, only males with the C-allele in the lowest tertile of physical activity increased their prevalence of T2D, demonstrating a kinesio-genomic interaction. High-fat fed, male mice injected with MOTS-c showed reduced weight and improved glucose tolerance, but not K14Q-MOTS-c treated mice. Like the human data, female mice were unaffected. Mechanistically, K14Q-MOTS-c leads to diminished insulin-sensitization <i>in vitro</i>. Thus, the m.1382A&gt;C polymorphism is associated with susceptibility to T2D in men, possibly interacting with exercise, and contributing to the risk of T2D in sedentary males by reducing the activity of MOTS-c.

Study Information

Provider

pubmed

Year

2021

Date

2021-01-19T00:00:00.000Z

DOI

10.18632/aging.202529